本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neumora Therapeutics, Inc.

1.04
-0.1000-8.77%
盤後1.060.0200+1.92%19:56 EDT
成交量:188.08萬
成交額:199.87萬
市值:1.96億
市盈率:-0.85
高:1.16
開:1.16
低:1.02
收:1.14
52周最高:3.65
52周最低:0.8302
股本:1.88億
流通股本:1.16億
量比:3.27
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-1.2237
每股收益(LYR):-1.4501
淨資產收益率:-187.11%
總資產收益率:-73.85%
市淨率:4.39
市盈率(LYR):-0.72

資料載入中...

2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/07/27

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/04

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities